Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   TNF plays a crucial role in inflammation by signaling via T cell TNFR2
  2. Alam, Muhammad S.; Otsuka, Shizuka; Wong,Nathan; Abbasi, Aamna; Gaida, Matthias M.; Fan, Yu; Meerzaman, Daoud; Ashwell, Jonathan D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2021, Dec 14; 118(50):
  1. 2.   Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis
  2. Hu, Yingwen; Wang, Bingbing; Shen, Jiayin; Low, Stewart A; Putt, Karson S; Niessen, Hans W M; Matteson, Eric L; Murphy, Linda; Ruppert, Clemens; Jansen, Gerrit; Oliver, Stephen J; Feng,Yang; Dimitrov, Dimiter S; Nickerson-Nutter, Cheryl; Low, Philip S
  3. Arthritis research & therapy. 2019, Jun 07; 21(1): 143.
  1. 3.   Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency
  2. Kuhns, Doug; Fink, Dani; Choi, U.; Sweeney, C.; Lau, K.; Long-Priel, Debra; Riva, D.; Mendez, L.; Uzel, G.; Freeman, A. F.; Olivier, K. N.; Anderson, V. L.; Currens, R.; Mackley, V.; Kang, A.; Al-Adeli, M.; Mace, E.; Orange, J. S.; Kang, E.; Lockett, S. J.; Chen, Steinbach, P. J.; Hsu, A. P.; Zarember, K. A.; Malech, H. L.; Gallin, J. I.; Holland, S. M.
  3. Blood. 2016, 27-Oct; 128(17): 2135-2143.
  1. 4.   Hypomorphic Rag mutations can cause destructive midline granulomatous disease
  2. De Ravin, S. S.; Cowen, E. W.; Zarember, K. A.; Whiting-Theobald, N. L.; Kuhns, D. B.; Sandler, N. G.; Douek, D. C.; Pittaluga, S.; Poliani, P. L.; Lee, Y. N.; Notarangelo, L. D.; Wang, L.; Alt, F. W.; Kang, E. M.; Milner, J. D.; Niemela, J. E.; Fontana-Penn, M.; Sinal, S. H.; Malech, H. L.
  3. Blood. 2010, Aug; 116(8): 1263-1271.
  1. 5.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 6.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 7.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 8.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 9.   Angiogenesis as an immunopharmacologic target in inflammation and cancer
  2. Bian, X. W.; Chen, J. H.; Jiang, X. F.; Bai, J. S.; Wang, Q. L.; Zhang, X.
  3. International Immunopharmacology. 2004, NOV; 4(12): 1537-1547.
  1. 10.   Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: Role of p38 mitogen-activated protein kinase and NF-kappa B
  2. Matsuyama, W.; Wang, L. H.; Farrar, W. L.; Faure, M.; Yoshimura, T.
  3. Journal of Immunology. 2004 172(4): 2332-2340.
  1. 11.   Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1)
  2. Zeller, J. C.; Panoskaltsis-Mortari, A.; Murphy, W. J.; Ruscetti, F. W.; Narula, S.; Roncarolo, M. G.; Blazar, B. R.
  3. Journal of Immunology. 1999 163(7): 3684-3691.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel